If EAA Test Versus LAL Test is Always Clinically Better and Whether Any Test Always Relates to the Therapeutic Value of Hemoperfusion in Septic Shock Patients?
- PMID: 37549019
- DOI: 10.1097/SHK.0000000000002201
If EAA Test Versus LAL Test is Always Clinically Better and Whether Any Test Always Relates to the Therapeutic Value of Hemoperfusion in Septic Shock Patients?
References
-
- Munford RS. Endotoxemia-menace, marker, or mistake? J Leukoc Biol . 100(4):687–698, 2016.
-
- Tamura H, Reich J, Nagaoka I. Outstanding contributions of LAL technology to pharmaceutical and medical science: review of methods, progress, challenges, and future perspectives in early detection and management of bacterial infections and invasive fungal diseases. Biomedicines . 9(5):536, 2021.
-
- Matsumoto N, Takahashi G, Kojika M, et al. Interleukin-8 induces an elevation in the endotoxin activity assay (EAA) level: does the EAA truly measure the endotoxin level? J Infect Chemother . 19(5):825–832, 2013.
-
- Ishihata K, Kakihana Y, Yasuda T, et al. Newly developed endotoxin measurement method (the Endotoxin Activity Assay) may reflect the severity of sepsis. Open J Pathol . 3:1–6, 2013. Google Scholar.
-
- Dellinger RP, Bagshaw SM, Antonelli M, et al; EUPHRATES Trial Investigators. Effect of targeted polymyxin B hemoperfusion on 28-day mortality in patients with septic shock and elevated endotoxin level: the EUPHRATES randomized clinical trial. JAMA . 320(14):1455–1463, 2018.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources